CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 27 enrolled
Drug / intervention
Cholecalciferol +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03406897
NCT03406897Phase 2Completed
CompareCT.gov

A Pilot, Safety and Feasibility Trial of High-Dose Omega-3 Fatty Acids and High-Dose Cholecalciferol (Vitamin D) Supplementation in Type 1 Diabetes

Rodolfo Alejandro·interventional·Posted Jan 23, 2018·Updated Sep 17, 2025

In Brief

A Phase 2 clinical trial evaluating Cholecalciferol and Omega 3 fatty acid for Diabetes Mellitus, Type 1 and 3 related conditions. Completed, enrolled 27 participants across 1 site.

Detailed Summary

The investigator propose to test the safety and efficacy of a regimen that combines Omega-3 Fatty Acids and Vitamin D in a design that considers timing and duration of administration in relation to their effects and predicted synergies.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus, Type 1, Hypoglycemia, Diabetes Mellitus, Diabetes, Autoimmune
CountriesUnited States
CollaboratorsDiabetes Research Institute Foundation

Timeline

Phase 2CompletedFinished
201820192020202120222023202420252026
First PostedJan 23, 2018
Enrollment StartJul 23, 2018
Primary CompletionJul 31, 2024
TodayJul 2, 2026
Enrollment to primary: 6.0 yearsPosted 8.4 years ago

Interventions

Cholecalciferoldrug

Oral Administration

Omega 3 fatty aciddrug

Oral Administration